Start with the claim
Name exactly what you heard: a mechanism, a benefit, a safety promise, or an approval claim.
Independent public peptide educationEditorial and review policy
Evidence before excitement
Understand the evidence before the claim.
Peptide Harbor translates clinical research, regulatory status, safety signals, and the claims people see in forums into clear public guidance. No sales catalog, no dosing advice, and no account required.
Open access - No account required - Reviewed sources - Human help when the guide is not enough
Start with a molecule
Eight evidence maps for the questions people ask most
Metabolic medicines
Semaglutide
Semaglutide has substantial human evidence and several FDA-approved uses, but the approved indication, formulation, and safety instructions depend on the specific product. A product sold with the same molecule name is not automatically equivalent to an FDA-approved medicine.
Substantial human evidence for specific approved usesMetabolic medicinesTirzepatide
Tirzepatide is an FDA-approved medicine for specific uses and has substantial human evidence. That does not make every online or compounded tirzepatide product approved, equivalent, or appropriate for a particular person.
Substantial human evidence for specific approved usesInvestigational metabolic peptidesRetatrutide
Retatrutide is an investigational triple-receptor agonist. A phase 2 obesity trial reported large average weight reductions in some groups, but phase 3 evaluation and regulatory review are distinct steps, and retatrutide is not an FDA-approved medicine as of this review.
Encouraging human evidence; confirmatory development continuesInvestigational repair peptidesBPC-157
BPC-157 is not an FDA-approved drug. Most benefit claims come from laboratory or animal work and personal reports. A recruiting phase 2 hamstring study is important to watch, but it has not yet produced results.
Primarily preclinical evidence; human outcome evidence is not establishedUnapproved repair peptidesTB-500
TB-500 is not an FDA-approved treatment. Online recovery claims often borrow from broader thymosin beta-4 biology, but FDA reports no identified human exposure data for the TB-500 fragment and lacks enough information to determine harm.
Insufficient human evidenceGrowth-hormone-axis peptidesCJC-1295
CJC-1295 can alter growth hormone and IGF-1 in small early human studies, but that does not establish anti-aging, muscle-building, recovery, or wellness benefits. It is not an FDA-approved treatment, and FDA reports limited clinical data plus serious adverse events.
Limited early human evidence focused on biomarkersMitochondrial-derived peptidesMOTS-c
MOTS-c is a mitochondrial-derived peptide studied in metabolism and exercise biology. Research showing that the body produces it or that mice respond to experimental treatment does not establish that synthetic MOTS-c is a safe or effective human therapy.
Primarily preclinical and observational human evidenceMitochondrial medicinesElamipretide (SS-31)
Elamipretide is FDA-approved under accelerated approval as Forzinity to improve muscle strength in people with Barth syndrome who weigh at least 30 kg. That narrow approval does not establish it as a general anti-aging, energy, exercise, or mitochondrial wellness treatment.
Limited human evidence supporting a narrow accelerated approvalFrom forums to facts
Familiar claims, reviewed without ridicule
We begin with what people actually read online, explain why it sounds plausible, then show what the current evidence can and cannot support.
Open the Claims CenterA useful signal, not human proof"If a peptide works in animals, it probably works in people."Natural does not mean risk-free"Peptides are natural or already in the body, so they are safer than ordinary drugs."A label is not human-use authorization"A 'research use only' label makes a peptide legal or acceptable for personal human use."Not FDA-approved"BPC-157 is FDA-approved now because FDA reviewed it or because a phase 2 trial exists."
A better reading habit
Move from a persuasive story to a checkable question
Check the human evidence
Separate animal work, early human studies, controlled trials, and approved clinical uses.
Read the safety gaps
Known reactions and unknown risks both matter, especially when product identity is uncertain.
Know the next step
Use the guide to prepare better questions, then involve a licensed clinician for personal decisions.
Still unclear after reading?
Ask for help understanding the public evidence.
Ask Harbor helps locate the relevant reviewed page. WhatsApp can clarify general evidence language. Personal symptoms, diagnosis, treatment, product selection, and medical decisions must go to a licensed clinician.